Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Vanflyta (quizartinib dihydrochloride) — Daiichi Sankyo Europe GmbH
Vanflyta (quizartinib dihydrochloride) has been authorised in Europe for leukemia/myeloid indications.
-
EMA approval · 2026-07-17EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.
EMA has authorised Inaqovi (cedazuridine/decitabine) for leukemias with myeloid involvement, expanding available treatment options.
-
EMA approval · 2026-06-25EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.
EMA has authorised Inaqovi (cedazuridine; decitabine) for use in leukemia with a myeloid therapeutic focus.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-0610 with and without ruxolitinib in hematologic and myeloproliferative malignancies; study complete…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Case-Control Study of Pesticides and Childhood Leukemia
This update reports the completion of a case-control study sponsored by the National Cancer Institute examining the association between pest…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers [Phase 2]
Phase 2 clinical trial update describing stem cell transplantation for participants with germline RUNX1-associated blood cancers; the trial …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Natural History Study of Early Life Exposures in Agriculture (ELEA)
An update on the ELEA natural history study sponsored by the National Cancer Institute investigating how early life exposures in agriculture…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
This update describes improved methods for selecting donor cells used in bone marrow transplant alternatives, and the trial is currently rec…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
A clinical trial update describing cognitive aftereffects of neurotoxicity in children and young adults with relapsed/refractory hematologic…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Action of the Vidaza on the Atrial Fibrillation
This clinical trial update reports the results of a completed study evaluating the effect of Vidaza (azacitidine) on atrial fibrillation in …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Familial Investigations of Childhood Cancer Predisposition
An ongoing St. Jude-led clinical trial is investigating familial cancer predisposition syndromes in children and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Managed Access Programs for CTL019, Tisagenlecleucel
Novartis’ CAR-T therapy tisagenlecleucel (CTL019) is the subject of a clinical trial update focused on managed access programs, including ly…
-
CLINICAL_TRIALS other · 2026-04-23Clinical Trial Update: Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma [NA]
A St. Jude Children's Research Hospital study is evaluating remote methods to identify autonomic dysfunction in survivors of leukemia and ly…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) [Phase 1, Phase 2]
A Phase 1/2 clinical trial (cAMeLot-1) is evaluating Bleximenib in participants with acute leukemia. The study is currently in recruitment.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy [NA]
This clinical trial update outlines a study to define the role of palliative care for patients with hematologic malignancies undergoing adop…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin)…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
The document reports specimen collection activities for the Agricultural Health Study pesticide exposure cohort, a National Cancer Institute…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Epidemiological Study of Korean Radiation Workers
An epidemiological study in Korea examining occupational radiation exposure and the associated risk of radiation-induced neoplasms and leuke…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
A clinical trial update describing leukapheresis collection for manufacturing CAR or adoptive cell therapies, with enrollment by invitation …
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. [Phase 1, Phase 2]
This clinical trial update outlines a Phase 1/2 study evaluating radioligand therapy with [177Lu]Lu-PentixaTher targeting CXCR4 in relapsed/…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Pre-malignant States to Hematologic Malignancies in Firefighters
A Wake Forest trial investigates progression from pre-malignant hematologic states to blood cancers in firefighters and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating the combination of trametinib and azacitidine for newly diagnosed juvenile myelomonocytic leukemia (J…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating CD45RA-depleted stem cell addback to prevent viral or fungal infections following TCRab/CD19-deplet…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients [Phase 1]
A Phase Ia/Ib clinical trial update describes testing Revumenib in combination with cytarabine, daunorubicin, and gemtuzumab ozogamicin in f…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia [Phase 1]
A Phase 1 clinical trial evaluating a radiolabeled 14C-Bleximenib in patients with acute leukemia. The study is currently recruiting.